Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model
BackgroundIn this study, we systematically evaluated the efficacy of mesenchymal stem cell (MSC) derived exosomes (MSC-exos) in the treatment of osteoarthritis (OA) through multimodal evaluation of cartilage protection, anti-inflammatory activity and tissue regeneration. A comparative analysis of dr...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1588841/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849699021847789568 |
|---|---|
| author | Zhe Wang Zihao Hu Lin Niu Yongsheng Xu Yansong Qi |
| author_facet | Zhe Wang Zihao Hu Lin Niu Yongsheng Xu Yansong Qi |
| author_sort | Zhe Wang |
| collection | DOAJ |
| description | BackgroundIn this study, we systematically evaluated the efficacy of mesenchymal stem cell (MSC) derived exosomes (MSC-exos) in the treatment of osteoarthritis (OA) through multimodal evaluation of cartilage protection, anti-inflammatory activity and tissue regeneration. A comparative analysis of drug delivery strategies was performed to explore better therapeutic effects.MethodsThe study employed a systematic search of PubMed, Embase, and Web of Science databases for comparative studies on exosome treatments in rat knee OA models with cartilage damage up to July 2024. Two researchers independently reviewed the literature, extracted data, evaluated bias, and conducted a meta-analysis using RevMan 5.4.1, Stata IC 15, and Stata 18.ResultsOur systematic review incorporated 28 preclinical studies demonstrating that MSC-exos consistently exhibited therapeutic advantages in cartilage repair, as evidenced by significant improvements across validated histological scoring systems, such as Osteoarthritis Research Society International (OARSI), Mankin, and International Cartilage Repair Society (ICRS) metrics. Mechanistic analyses revealed coordinated anabolic-catabolic modulation, with marked upregulation of cartilage-specific anabolic factors including collagen type II, aggrecan core protein, and interleukin-10. Concomitantly, MSC-exos suppressed pro-inflammatory mediators through downregulation of interleukin-1β, interleukin-6, matrix metalloproteinase-13, and tumor necrosis factor-alpha, critical regulators of extracellular matrix degradation in OA pathogenesis. Subgroup analysis of MSC types may suggest that exosomes derived from synovial fluid mesenchymal stem cells (SF-MSC-exos) and umbilical cord mesenchymal stem cells (UMSC-exos) have better effects on cartilage repair. Biweekly exosome injections are more effective than weekly injections in repairing OA.ConclusionThis meta-analysis, by combining existing evidence with network meta-analysis, suggests that UMSC-exos and SF-MSC-exos are the most effective treatment options and that twice-weekly doses are the optimal frequency of treatment. MSC-exos significantly improved the histopathological score of oOA through bidirectional regulation of cartilage anabolic activation and catabolic inhibition. The results of the subgroup analysis provide suggestions for future clinical treatment of OA with exosomes. In the future, more high-quality randomised controlled animal and clinical trials are needed to determine the optimal type, frequency and dose of exosomes for OA treatment.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42024599998, PROSPERO, CRD42024599998. |
| format | Article |
| id | doaj-art-f6b03d2f60bd4485bfcbe1daf1dcb64c |
| institution | DOAJ |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-f6b03d2f60bd4485bfcbe1daf1dcb64c2025-08-20T03:18:44ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-06-011610.3389/fphar.2025.15888411588841Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat modelZhe Wang0Zihao Hu1Lin Niu2Yongsheng Xu3Yansong Qi4Orthopedic Center (Sports Medicine Center), Inner Mongolia Autonomous Region People’s Hospital, Hohhot, ChinaOrthopedic Center (Sports Medicine Center), Inner Mongolia Autonomous Region People’s Hospital, Hohhot, ChinaInner Mongolia Academy of Medical Sciences, Inner Mongolia Autonomous Region People’s Hospital, Hohhot, ChinaOrthopedic Center (Sports Medicine Center), Inner Mongolia Autonomous Region People’s Hospital, Hohhot, ChinaOrthopedic Center (Sports Medicine Center), Inner Mongolia Autonomous Region People’s Hospital, Hohhot, ChinaBackgroundIn this study, we systematically evaluated the efficacy of mesenchymal stem cell (MSC) derived exosomes (MSC-exos) in the treatment of osteoarthritis (OA) through multimodal evaluation of cartilage protection, anti-inflammatory activity and tissue regeneration. A comparative analysis of drug delivery strategies was performed to explore better therapeutic effects.MethodsThe study employed a systematic search of PubMed, Embase, and Web of Science databases for comparative studies on exosome treatments in rat knee OA models with cartilage damage up to July 2024. Two researchers independently reviewed the literature, extracted data, evaluated bias, and conducted a meta-analysis using RevMan 5.4.1, Stata IC 15, and Stata 18.ResultsOur systematic review incorporated 28 preclinical studies demonstrating that MSC-exos consistently exhibited therapeutic advantages in cartilage repair, as evidenced by significant improvements across validated histological scoring systems, such as Osteoarthritis Research Society International (OARSI), Mankin, and International Cartilage Repair Society (ICRS) metrics. Mechanistic analyses revealed coordinated anabolic-catabolic modulation, with marked upregulation of cartilage-specific anabolic factors including collagen type II, aggrecan core protein, and interleukin-10. Concomitantly, MSC-exos suppressed pro-inflammatory mediators through downregulation of interleukin-1β, interleukin-6, matrix metalloproteinase-13, and tumor necrosis factor-alpha, critical regulators of extracellular matrix degradation in OA pathogenesis. Subgroup analysis of MSC types may suggest that exosomes derived from synovial fluid mesenchymal stem cells (SF-MSC-exos) and umbilical cord mesenchymal stem cells (UMSC-exos) have better effects on cartilage repair. Biweekly exosome injections are more effective than weekly injections in repairing OA.ConclusionThis meta-analysis, by combining existing evidence with network meta-analysis, suggests that UMSC-exos and SF-MSC-exos are the most effective treatment options and that twice-weekly doses are the optimal frequency of treatment. MSC-exos significantly improved the histopathological score of oOA through bidirectional regulation of cartilage anabolic activation and catabolic inhibition. The results of the subgroup analysis provide suggestions for future clinical treatment of OA with exosomes. In the future, more high-quality randomised controlled animal and clinical trials are needed to determine the optimal type, frequency and dose of exosomes for OA treatment.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42024599998, PROSPERO, CRD42024599998.https://www.frontiersin.org/articles/10.3389/fphar.2025.1588841/fullexosomesmesenchymal stem cellscartilageosteoarthritiscartilage injury |
| spellingShingle | Zhe Wang Zihao Hu Lin Niu Yongsheng Xu Yansong Qi Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model Frontiers in Pharmacology exosomes mesenchymal stem cells cartilage osteoarthritis cartilage injury |
| title | Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model |
| title_full | Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model |
| title_fullStr | Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model |
| title_full_unstemmed | Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model |
| title_short | Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model |
| title_sort | mesenchymal stem cell derived exosomes for the treatment of knee osteoarthritis a systematic review and meta analysis based on rat model |
| topic | exosomes mesenchymal stem cells cartilage osteoarthritis cartilage injury |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1588841/full |
| work_keys_str_mv | AT zhewang mesenchymalstemcellderivedexosomesforthetreatmentofkneeosteoarthritisasystematicreviewandmetaanalysisbasedonratmodel AT zihaohu mesenchymalstemcellderivedexosomesforthetreatmentofkneeosteoarthritisasystematicreviewandmetaanalysisbasedonratmodel AT linniu mesenchymalstemcellderivedexosomesforthetreatmentofkneeosteoarthritisasystematicreviewandmetaanalysisbasedonratmodel AT yongshengxu mesenchymalstemcellderivedexosomesforthetreatmentofkneeosteoarthritisasystematicreviewandmetaanalysisbasedonratmodel AT yansongqi mesenchymalstemcellderivedexosomesforthetreatmentofkneeosteoarthritisasystematicreviewandmetaanalysisbasedonratmodel |